Literature DB >> 33301931

Typhoid fever infection - Antibiotic resistance and vaccination strategies: A narrative review.

Cristina Masuet-Aumatell1, Jorge Atouguia2.   

Abstract

Typhoid fever is a bacterial infection caused by the Gram-negative bacterium Salmonella enterica subspecies enterica serovar Typhi (S. Typhi), prevalent in many low- and middle-income countries. In high-income territories, typhoid fever is predominantly travel-related, consequent to travel in typhoid-endemic regions; however, data show that the level of typhoid vaccination in travellers is low. Successful management of typhoid fever using antibiotics is becoming increasingly difficult due to drug resistance; emerging resistance has spread geographically due to factors such as increasing travel connectivity, affecting those in endemic regions and travellers alike. This review provides an overview of: the epidemiology and diagnosis of typhoid fever; the emergence of drug-resistant typhoid strains in the endemic setting; drug resistance observed in travellers; vaccines currently available to prevent typhoid fever; vaccine recommendations for people living in typhoid-endemic regions; strategies for the introduction of typhoid vaccines and stakeholders in vaccination programmes; and travel recommendations for a selection of destinations with a medium or high incidence of typhoid fever.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bacterial; Drug resistance; Risk; Salmonella typhi; Travel; Typhoid-paratyphoid vaccines

Year:  2020        PMID: 33301931     DOI: 10.1016/j.tmaid.2020.101946

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


  2 in total

Review 1.  Targeting a highly conserved domain in bacterial histidine kinases to generate inhibitors with broad spectrum activity.

Authors:  Conrad A Fihn; Erin E Carlson
Journal:  Curr Opin Microbiol       Date:  2021-04-28       Impact factor: 7.584

2.  Spondylodiscitis due to Salmonella Typhi: a series of four cases.

Authors:  Kavitha Saravu; Shyamasunder N Bhat; Nitin Gupta
Journal:  Oxf Med Case Reports       Date:  2021-12-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.